Issue 61, 2023

Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma

Abstract

Transarterial chemoembolization (TACE) is one of the most commonly used treatments for hepatocellular carcinoma (HCC); however, the poor stability of emulsified chemotherapy drugs by iodinated oil always leads to serious systemic cytotoxicity. Herein, a composite hydrogel Epi/Etpoil@MC/XG was proposed by stably distributing ethiodized poppyseed oil (Etpoil) and epirubicin (Epi) in the blend hydrogel of methylcellulose (MC) and xanthan gum (XG). Benefiting from its adjusted thermo-responsive and injectable properties, the Epi/Etpoil@MC/XG has been successfully applied in the embolization of the feeding artery for a VX2 tumor model.

Graphical abstract: Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma

Supplementary files

Article information

Article type
Communication
Submitted
09 May 2023
Accepted
27 Jun 2023
First published
30 Jun 2023

Chem. Commun., 2023,59, 9352-9355

Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma

W. Zhao, J. Xu, Y. You, Z. Guo, Y. Xiang, K. Hao, X. He and P. Zhao, Chem. Commun., 2023, 59, 9352 DOI: 10.1039/D3CC02257A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements